← Eichor
Condition: Sentinel Lymph Node Biopsy Slnb Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Sentinel Lymph Node Biopsy Slnb

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
Phase 3 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT03351348Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery
Phase N/A · 12 location(s) · University Hospitals of Derby and Burton NHS Foundation Trus · NCT07085442Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Syste
NA · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT04293796Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergo
NA · 54 location(s) · University Hospital, Basel, Switzerland · NCT07140172Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Ca
Phase N/A · 1 location(s) · Yunnan Cancer Hospital · NCT07154563Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients
Phase 2 · 1 location(s) · National Cancer Center, Korea · NCT06780748Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer
NA · 7 location(s) · Isabelle Henskens · NCT07146295Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk
Phase 2 · 1 location(s) · University of California, Davis · NCT06990737Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)
NA · 2 location(s) · Isabelle Henskens · NCT07362485Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into
Phase N/A · 1 location(s) · Faculty of Medicine of Tunis · NCT07508306Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
Phase N/A · 14 location(s) · European Institute of Oncology · NCT07278726Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast Cancer
NA · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT07579286Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
NA · 3 location(s) · Tata Memorial Hospital · NCT05774483Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC
NA · 1 location(s) · European Institute of Oncology · NCT07080944Omission of SLNB in CN0 Early Breast Cancer
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05935150
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.